TRETINOIN, CYTARABINE, AND DAUNORUBICIN HYDROCHLORIDE WITH OR WITHOUT ARSENIC TRIOXIDE FOLLOWED BY TRETINOIN WITH OR WITHOUT MERCAPTOPURINE AND METHOTREXATE IN TREATING PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: